Active Ingredient History
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Bone Marrow Diseases (Phase 3)
Breast Neoplasms (Phase 2)
Carcinoma, Hepatocellular (Phase 3)
Colorectal Neoplasms (Phase 2)
Drug Therapy (Phase 3)
Esophageal Neoplasms (Phase 4)
General Surgery (Phase 2)
Nasopharyngeal Carcinoma (Phase 3)
Neoplasm Metastasis (Phase 2)
Neoplasms ()
Osteosarcoma (Phase 2/Phase 3)
Small Cell Lung Carcinoma (Phase 2)
Squamous Cell Carcinoma of Head and Neck (Phase 2)
Stomach Neoplasms (Phase 4)
Survival (Phase 2)
Toxicity Tests (Phase 1)
Triple Negative Breast Neoplasms (Phase 2)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue